CSIMarket
 
Cryoport inc   (CYRX)
Other Ticker:  
 
 

Cryoport Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cryoport Inc inventory turnover ratio, the Cryoport Inc 's ability to sell and replace its inventory in the forth quarter 2023, sequentially increased to 4.84 in the fourth quarter 2023, yet the ratio remained below the average, as CYRX's market remain challenging.Average inventory processing period, for the Cryoport Inc in Dec 31 2023 quarter, has decreased to 75 days, compare to 76 days, in the Sep 30 2023 quarter.

Within Healthcare sector 43 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 343 in the third quarter 2023, to 492.

CYRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cryoport Inc Market Share?

What is Inventory Turnover Ratio?


CYRX Inventory Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Inventory Growth -5.32 % 18.59 % 24.93 % 20.06 % 67.74 %
Y / Y Cost of Sales Growth -0.24 % -6.33 % -8.57 % 19.31 % 2.26 %
Inventory Turnover Ratio (TTM) 4.84 4.78 5.07 5.47 5.48
CYRX's Total Ranking # 492 # 343 # 343 # 343 # 499
Average inventory processing period 75 76 72 67 67
Seq. Inventory Growth -9.96 % 0.98 % 8.81 % -4.3 % 12.78 %
Seq. Cost of Sales Growth 6.61 % -1.23 % -9.67 % 4.88 % 0.1 %



Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 44
Overall Market # 492

Inventory Turnover Ratio Statistics
High Average Low
69.96 40.8 4.78
(Sep 30 2018)   (Sep 30 2023)




Financial Statements
Cryoport Inc 's Inventories $ 26 Millions Visit CYRX's Balance sheet
Cryoport Inc 's Cost of Revenues TTM $ 134 Millions Visit CYRX's Income Statement
What are CYRX's Sales? Visit CYRX's Sales by Segment

Other Inventory Turnover Ratios
Cryoport Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CYRX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CYRX's Competitors
Inventory Turnover Ratio for CYRX's Suppliers
Inventory Turnover Ratio for CYRX's Customers

You may also want to know
CYRX's Sales Growth Rates CYRX's Pe Price to earnings ratio CYRX's Receivables Turnover Ratio CYRX's Stock Quote
CYRX's Net Income Growth Rates CYRX's Ps Price to Sales ratio CYRX's Sales per Employee CYRX's Asset Turnover Ratio
CYRX's Net Margin CYRX's Pb Price to Book ratio CYRX's Financial Strength Ratios CYRX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2023 Inventories at quarter ending Dec 31 2023
Vanda Pharmaceuticals Inc   13.01 $ 14.796  Millions$ 1  Millions
Option Care Health Inc   12.80 $ 3,321.000  Millions$ 259  Millions
Eton Pharmaceuticals Inc   12.44 $ 10.000  Millions$ 1  Millions
Irhythm Technologies Inc   10.94 $ 160.000  Millions$ 15  Millions
Lantheus Holdings Inc   10.93 $ 586.000  Millions$ 54  Millions
Sotera Health Company  10.78 $ 472.000  Millions$ 44  Millions
Genedx Holdings Corp   10.67 $ 112.000  Millions$ 10  Millions
Myriad Genetics Inc   10.34 $ 236.200  Millions$ 23  Millions
Earth Science Tech Inc   10.26 $ 1.843  Millions$ 0  Millions
23andme Holding Co  10.20 $ 134.395  Millions$ 13  Millions
Moderna Inc   8.79 $ 4,693.000  Millions$ 534  Millions
Collegium Pharmaceutical Inc   8.76 $ 274.730  Millions$ 31  Millions
National Vision Holdings Inc   8.26 $ 1,000.910  Millions$ 121  Millions
Novavax inc  8.14 $ 343.768  Millions$ 42  Millions
Charles River Laboratories International inc   7.52 $ 2,295.983  Millions$ 305  Millions
Castle Biosciences Inc   7.39 $ 44.982  Millions$ 6  Millions
Alimera Sciences Inc   7.34 $ 10.837  Millions$ 1  Millions
Hims and Hers Health Inc   7.25 $ 157.000  Millions$ 22  Millions
Owens and Minor inc  7.06 $ 8,208.000  Millions$ 1,163  Millions
Kewaunee Scientific Corporation  6.88 $ 150.625  Millions$ 22  Millions
Hutchmed china Limited  6.61 $ 331.984  Millions$ 50  Millions
Fonar Corporation  6.39 $ 17.389  Millions$ 3  Millions
Veracyte inc   6.25 $ 88.913  Millions$ 14  Millions
Patterson Companies Inc   5.96 $ 5,166.391  Millions$ 867  Millions
Avantor Inc   5.30 $ 4,603.400  Millions$ 868  Millions
Lifemd Inc   5.28 $ 18.000  Millions$ 3  Millions
Incyte Corporation  5.18 $ 254.990  Millions$ 49  Millions
Enzo Biochem Inc  5.13 $ 49.539  Millions$ 10  Millions
Abbvie inc   5.11 $ 20,415.000  Millions$ 3,992  Millions
Integer Holdings Corporation  5.09 $ 1,178.000  Millions$ 232  Millions

Date modified: 2024-03-13T23:04:03+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com